MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 115 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,616,000 | +274.1% | 15,423 | +346.8% | 1.35% | +156.9% |
Q1 2019 | $432,000 | -49.6% | 3,452 | -13.7% | 0.52% | +219.5% |
Q3 2018 | $857,000 | -79.7% | 4,000 | -89.0% | 0.16% | -76.5% |
Q1 2018 | $4,231,000 | +229.5% | 36,226 | +26.9% | 0.70% | +111.2% |
Q3 2017 | $1,284,000 | – | 28,536 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |